Cardiovascular Diseases Clinical Trial
Official title:
High-intensity Interval Training Versus Moderate Intensity Continuous Training as a Means to Improve Cardiometabolic Health After Spinal Cord Injury
Verified date | January 2020 |
Source | Brock University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Testing the efficacy of high intensity interval training (HIIT), as compared to current research supporting moderate intensity continuous training (MICT), as a means to improve cardiometabolic health after spinal cord injury.
Status | Completed |
Enrollment | 8 |
Est. completion date | December 15, 2019 |
Est. primary completion date | May 30, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Individuals with a spinal cord injury (paraplegia or tetraplegia, complete or incomplete) who are at least one-year post injury. - Declared medically stable, and able to communicate clearly in English. |
Country | Name | City | State |
---|---|---|---|
Canada | Brock University | St. Catherines | Ontario |
Lead Sponsor | Collaborator |
---|---|
Brock University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Waist circumference (inches) | Central adiposity will be measured by tape measure to monitor possible weight loss | 6 weeks | |
Primary | Cholesterol | Total and HDL cholesterol will be measured in serum | 6 weeks | |
Primary | Triglycerides | Triglycerides will be measured in serum | 6 weeks | |
Primary | Glycated Hemoglobin (HbA1c) | Glycated hemoglobin will be measured in whole blood as an indicator of diabetic risk | 6 weeks | |
Primary | Tumor necrosis factor (TNF-a) | TNF-a will be used as an inflammatory representative and will be measured in serum | 6 weeks | |
Primary | Interleukin - 10 (IL-10) | IL-10 will will be used as an anti-inflammatory representative and will be measured in serum | 6 weeks | |
Primary | Pulse Wave Velocity | Arterial stiffness, a common measure for cardiac risk will be measured | 6 weeks | |
Primary | Blood pressure | Measured through a digital cuff, the focus will be on both systolic and diastolic | 6 weeks | |
Primary | Peak Oxygen Consumption (VO2 peak) | VO2 peak will be measured by a Moxus metabolic cart to determine changes in fitness | 6 weeks | |
Primary | C Reactive Protein (CRP) | CRP will will be used as an inflammatory representative and will be measured in serum | 6 weeks | |
Primary | Leptin | Leptin will will be used as a body fat representative and will be measured in serum | 6 weeks | |
Primary | Adiponectin | Adiponectin will will be used as a surrogate for insulin resistance and will be measured in serum | 6 weeks | |
Secondary | Physical Activity Enjoyment Scale (PACES) | All participants will complete the physical activity enjoyment scale (PACES) to indicate enjoyment of HIIT. With a total of 18 questions, options 1 through 7 going from a positive to a negative overall experience with the HIIT protocol will be documented. | 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|